# E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

> **NCT04190862** · PHASE1 · RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 39 (estimated)

## Conditions studied

- Anal Fistula

## Interventions

- **DRUG:** E-CEL UVEC

## Key facts

- **NCT ID:** NCT04190862
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-22
- **Primary completion:** 2026-09-30
- **Final completion:** 2032-06-30
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04190862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04190862, "E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04190862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*